- Home
- ABUS vs CBNK Comparison
ABUS vs CBNK Comparison
Compare ABUS & CBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- CBNK
- Stock Information
- Founded
- ABUS 2005
- CBNK 1974
- Country
- ABUS United States
- CBNK United States
- Employees
- ABUS N/A
- CBNK N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- CBNK Major Banks
- Sector
- ABUS Health Care
- CBNK Finance
- Exchange
- ABUS Nasdaq
- CBNK Nasdaq
- Market Cap
- ABUS 611.0M
- CBNK 517.6M
- IPO Year
- ABUS N/A
- CBNK 2018
- Fundamental
- Price
- ABUS $3.22
- CBNK $34.24
- Analyst Decision
- ABUS Strong Buy
- CBNK Hold
- Analyst Count
- ABUS 4
- CBNK 1
- Target Price
- ABUS $5.50
- CBNK $35.00
- AVG Volume (30 Days)
- ABUS 774.3K
- CBNK 79.1K
- Earning Date
- ABUS 08-04-2025
- CBNK 08-05-2025
- Dividend Yield
- ABUS N/A
- CBNK 1.17%
- EPS Growth
- ABUS N/A
- CBNK 6.54
- EPS
- ABUS N/A
- CBNK 2.49
- Revenue
- ABUS $6,403,000.00
- CBNK $188,910,000.00
- Revenue This Year
- ABUS $3.35
- CBNK $46.92
- Revenue Next Year
- ABUS N/A
- CBNK $7.82
- P/E Ratio
- ABUS N/A
- CBNK $13.73
- Revenue Growth
- ABUS N/A
- CBNK 20.92
- 52 Week Low
- ABUS $2.71
- CBNK $22.69
- 52 Week High
- ABUS $4.73
- CBNK $36.40
- Technical
- Relative Strength Index (RSI)
- ABUS 48.90
- CBNK 49.66
- Support Level
- ABUS $3.08
- CBNK $33.46
- Resistance Level
- ABUS $3.30
- CBNK $36.40
- Average True Range (ATR)
- ABUS 0.10
- CBNK 0.91
- MACD
- ABUS 0.01
- CBNK -0.17
- Stochastic Oscillator
- ABUS 50.00
- CBNK 26.53
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About CBNK Capital Bancorp Inc.
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.